Literature DB >> 12073829

Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey.

D Colak1, D Ogunc, F Gunseren, S Velipasaoglu, M R Aktekin, M Gültekin.   

Abstract

Hepatitis A and hepatitis E are enteric transmitted viral diseases occurring in epidemic and sporadic forms especially in developing countries. Previous studies in Turkey showed that most residents are infected with HAV by the second decade of life. Since HEV is generally transmitted by the same route as HAV we conducted a community-based seroprevalence study for HAV and HEV infection in Ahatli area in Antalya, Turkey where socioeconomic conditions are low. Anti-HAV total immunoglobulin was tested by using a microparticle EIA (Axsym-Abbott Lab). Anti-HEV IgG was assayed by a micro ELISA method (Genelabs-Singapore). Of the 338 sera tested, 112 (33.1%) were positive for anti-HAV total antibody. Anti-HEV IgG was detected in three (0.89%) of the serum samples. Seropositivity rates of HAV in preschool and school children were 19.9% and 43.9% respectively (p < 0.001). No antibody to HEV was detected in preschool children, while the prevalence of anti-HEV IgG was 1.6% in children attending school. Our data showed that seroprevalence of anti-HAV is high among children samples but HEV infection appears to be relatively rare in pediatric age groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12073829     DOI: 10.1556/AMicr.49.2002.1.9

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  11 in total

1.  Epidemiology of hepatitis E virus in children in the province of Van, Turkey.

Authors:  Gülsüm İclal Bayhan; Kaan Demiören; Hüseyin Güdücüoğlu
Journal:  Turk Pediatri Ars       Date:  2016-09-01

Review 2.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

3.  Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.

Authors:  M Herremans; E Duizer; E Jusic; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  Hepatitis E virus IgG seroprevalence in liver transplant patients: A retrospective single-center experience.

Authors:  Ferit Celik; Ali Senkaya; Nalan Gulsen Unal; Seymur Aslanov; Alper Uysal; Aysin Zeytinoglu; Ilker Turan; Murat Zeytunlu; Omer Ozutemiz; Ulus Salih Akarca; Zeki Karasu; Fulya Gunsar
Journal:  Hepatol Forum       Date:  2021-01-08

5.  Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran.

Authors:  Ali Jafari Mehr; Mohammad Javad Ehsani Ardakani; Mehdi Hedayati; Saeed Shahraz; Elnaz Jafari Mehr; Mohammad Reza Zali
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.

Authors:  M Herremans; J Bakker; E Duizer; H Vennema; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

7.  Seroprevalence and predictors of hepatitis A infection in Nigerian children.

Authors:  Joanah Moses Ikobah; Henry Chima Okpara; Emmanuel Eyo Ekanem; Jacob Jackson Udo
Journal:  Pan Afr Med J       Date:  2015-02-12

Review 8.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

9.  Seroprevalence of hepatitis e virus among primary school children.

Authors:  Nural Cevahir; Melek Demir; Ali Ihsan Bozkurt; Ahmet Ergin; Ilknur Kaleli
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

Review 10.  Hepatitis E virus infection in Turkey: a systematic review.

Authors:  Hakan Leblebicioglu; Resat Ozaras
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-05-02       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.